colonic polyps
Conditions
Sponsors
NTT Medical Center Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Age 20 years or older at the time of enrollment. ECOG performance status of 0 or 1. Laboratory values within 30 days prior to enrollment meet all of the following (no blood transfusion within 14 days prior to the labs used for enrollment): ??. Hemoglobin equal to or greater than 9 g/dL ??. Platelet count equal to or greater than 100000/mm3 ??. AST and ALT less than or equal to 100 IU/L ??. Serum creatinine less than or equal to 2.0 mg/dL Ability to be followed for 30 days post-procedure. Written informed consent obtained for participation in the study. An adult cohabitant must be present in the participant's household, and the participant must be able to visit the hospital within 2 hours if necessary.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: History of endoscopic treatment for lower gastrointestinal lesions within 30 days prior to enrollment. Planned endoscopic treatment for the lower gastrointestinal tract within 30 days after enrollment. Women who are pregnant, possibly pregnant, or breastfeeding. Patients with psychiatric disorders that impair their ability to fully understand the study. History of myocardial infarction or unstable angina within the past 3 months. Known coagulation disorders. Active bacterial or fungal infections, defined as a body temperature of 38.5 degrees Celsius or higher with radiological or microbiological evidence of infection. Respiratory diseases requiring continuous oxygen therapy. Patients undergoing dialysis. Uncontrolled hypertension. Any case deemed unsuitable for participation in the study by the attending physician. Sporadic localized tumors or dysplasia-associated lesions or masses (DALMs) associated with chronic inflammation such as ulcerative colitis. Lesions with local residual disease after previous endoscopic resection or those located at postoperative anastomotic sites.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors for the development of adverse events | — |
Countries
Japan
Contacts
Public ContactShinya Nagae
NTT Medical Center Tokyo Department of Gastrointestinal Endoscopy
Outcome results
None listed